Neuropathological relationship between major depression and dementia: A hypothetical model and review

被引:86
作者
Kim, Helena Kyunghee [1 ,2 ]
Nunes, Paula Villela [3 ]
Oliveira, Katia C. [3 ]
Young, L. Trevor [1 ,2 ]
Lafer, Beny [3 ]
机构
[1] Univ Toronto, Dept Psychiat, RM4204,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Pharmacol, RM4204,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada
[3] Univ Sao Paulo, Sch Med, Dept Psychiat, Bipolar Disorder Program PROMAN, Rua Dr Ovidio Pires de Campos 785, BR-3671 Sao Paulo, Brazil
基金
加拿大健康研究院; 巴西圣保罗研究基金会;
关键词
Major depressive disorder; Neurodegeneration; Dementia; LATE-LIFE DEPRESSION; DORSOLATERAL PREFRONTAL CORTEX; MAGNETIC-RESONANCE-SPECTROSCOPY; ANTERIOR CINGULATE CORTEX; C-REACTIVE PROTEIN; GAMMA-AMINOBUTYRIC-ACID; GLIAL-CELL PATHOLOGY; BIPOLAR DISORDER; MOOD DISORDERS; HIPPOCAMPAL VOLUME;
D O I
10.1016/j.pnpbp.2016.01.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Major depression (MDD) is a chronic psychiatric condition in which patients often show increasing cognitive impairment with recurring episodes. Neurodegeneration may play an important component in the pathogenesis of MDD associated with cognitive complaints. In agreement with this, patients with MDD show decreased brain volumes in areas implicated in emotional regulation and cognition, neuronal and glial cell death as well as activation of various pathways that can contribute to cell death. Therefore, the aim of this review is to provide an integrative overview of potential contributing factors to neurodegeneration in MDD. Studies have reported increased neuronal and glial cell death in the frontal cortex, amygdala, and hippocampus of patients with MDD. This may be due to decreased neurogenesis from lower levels of brain-derived neurotrophic factor (BDNF), excitotoxicity from increased glutamate signaling, and lower levels of gamma-aminobutyric acid (GABA) signaling. In addition, mitochondrial dysfunction and oxidative stress are found in similar brain areas where evidence of excitotoxicity has been reported. Also, levels of antioxidant enzymes were reported to be increased in patients with MDD. Inflammation may also be a contributing factor, as levels of inflammatory cytokines were reported to be increased in the prefrontal cortex of patients with MDD. While preliminary, studies have also reported neuropathological alterations in patients with MDD. Together, these studies suggest that lower BDNF levels, mitochondrial dysfunction, oxidative stress, inflammation and excitotoxicity may be contributing to neuronal and glial cell death in MDD, leading to decreased brain volume and cognitive dysfunction with multiple recurrent episodes. This highlights the need to identify specific pathways involved in neurodegeneration in MDD, which may elucidate targets that can be treated to ameliorate the effects of disease progression in this disorder. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 118 条
  • [1] Neurobiological mechanisms in major depressive disorder
    aan het Rot, Marije
    Mathew, Sanjay J.
    Charney, Dennis S.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 180 (03) : 305 - 313
  • [2] GDNF, NGF and BDNF as therapeutic options for neurodegeneration
    Allen, Shelley J.
    Watson, Judy J.
    Shoemark, Deborah K.
    Barua, Neil U.
    Patel, Nikunj K.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2013, 138 (02) : 155 - 175
  • [3] Reduced glutamate in the anterior cingulate cortex in depression:: An in vivo proton magnetic resonance spectroscopy study
    Auer, DP
    Pütz, B
    Kraft, E
    Lipinski, B
    Schill, J
    Holsboer, F
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (04) : 305 - 313
  • [4] The role of cognitive impairment in general functioning in major depression
    Baune, Bernhard T.
    Miller, Robyn
    McAfoose, Jordan
    Johnson, Melissa
    Quirk, Frances
    Mitchell, David
    [J]. PSYCHIATRY RESEARCH, 2010, 176 (2-3) : 183 - 189
  • [5] Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration
    Bell-McGinty, S
    Butters, MA
    Meltzer, CC
    Greer, PJ
    Reynolds, CF
    Becker, JT
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (08) : 1424 - 1427
  • [6] Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression
    Bernard, R.
    Kerman, I. A.
    Thompson, R. C.
    Jones, E. G.
    Bunney, W. E.
    Barchas, J. D.
    Schatzberg, A. F.
    Myers, R. M.
    Akil, H.
    Watson, S. J.
    [J]. MOLECULAR PSYCHIATRY, 2011, 16 (06) : 634 - 646
  • [7] Low glial numbers in the amygdala in major depressive disorder
    Bowley, MP
    Drevets, WC
    Öngür, D
    Price, JL
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (05) : 404 - 412
  • [8] Brodal P., 2010, The central nervous system structure and function, V4th
  • [9] History of depression prior to Alzheimer's disease and vascular dementia verified post-mortem
    Brunnstrom, Hans
    Passant, Ulla
    Englund, Elisabet
    Gustafson, Lars
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2013, 56 (01) : 80 - 84
  • [10] A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
    Brunoni, Andre Russowsky
    Lopes, Mariana
    Fregni, Felipe
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 (08) : 1169 - 1180